CAR-T Cells for Cancer Treatment: Current Design and Next Frontiers
Author:
Publisher
Springer US
Link
http://link.springer.com/content/pdf/10.1007/978-1-0716-0146-4_1
Reference37 articles.
1. Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264
2. Mathis S, Vallat JM, Magy L (2016) Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy. Immunotherapy 8:165–178
3. Kershaw MH, Westwood JA, Slaney CY et al (2014) Clinical application of genetically modified T cells in cancer therapy. Clin Transl Immunology. 3:e16
4. Batlevi CL, Matsuki E, Brentjens RJ et al (2015) Novel immunotherapies in lymphoid malignancies. Nat Rev Clin Oncol 13:1–17
5. Maus MV, Grupp SA, Porter DL et al (2014) Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood 123:2625–2635
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Editorial: Non-cellular immunotherapies in pediatric malignancies;Frontiers in Immunology;2024-02-21
2. Agonistic Bivalent Human scFvs-Fcγ Fusion Antibodies to OX40 Ectodomain Enhance T Cell Activities against Cancer;Vaccines;2023-12-07
3. The shifting roles and toxicities of cellular therapies in B‐cell malignancies;Transplant Infectious Disease;2023-09-07
4. Cellular Therapies: A Description of the Types of Existing Cellular Therapies and Associated Toxicities;Palliative Care in Hematologic Malignancies and Serious Blood Disorders;2023
5. ROR1-targeting switchable CAR-T cells for cancer therapy;Oncogene;2022-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3